Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Recombinant zoster vaccine immunization rate in patients on Janus kinase inhibitors for rheumatologic and dermatologic conditions.

Rheumatology advances in practice·2026
Same author

Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival.

Transplantation and cellular therapy·2026
Same author

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026
Same author

Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Blood cancer journal·2026
Same author

Base Editing of <i>HBG1</i> and <i>HBG2</i> Promoters for Sickle Cell Disease.

The New England journal of medicine·2026
Same author

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy.

Transplantation and cellular therapy·2026

相关实验视频

Updated: Jul 18, 2025

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.0K

血液学研究中的终点选择和评估.

Ruta Brazauskas1, Mary Eapen2, Tao Wang1

  • 1Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.

Best practice & research. Clinical haematology
|August 23, 2023
PubMed
概括
此摘要是机器生成的。

本综述详细介绍了血液病研究的常见结果和终点,强调了治疗安全性和疗效的临床结果. 它还强调了患者报告的结果,并为在临床试验中选择初级和二级终点提供了指导.

关键词:
临床试验中的临床试验.复合终点是复合的终点.终点 终点 终点血液学 血液学 血液学结果的结果.患者报告的结果.主要终点主要终点替代终点是替代终点.

更多相关视频

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.3K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K

相关实验视频

Last Updated: Jul 18, 2025

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.0K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.3K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K

科学领域:

  • 血液学 血液学 血液学
  • 临床试验 临床试验
  • 生物统计学 生物统计学

背景情况:

  • 血液学研究评估血液疾病的治疗方法,重点关注疾病进展,生存和生活质量等结果.
  • 选择适当的终点对于有意义的研究结果和关于治疗有效性的有意义信息至关重要.

研究的目的:

  • 审查血液病研究中常用的结果和终点.
  • 为这些终点的统计分析提供准则.
  • 讨论代用和复合终点的作用以及患者报告结果的重要性.

主要方法:

  • 关于血液学观察研究和临床试验的文献综述.
  • 描述经常使用的临床结果和终点.
  • 对血液学终点的统计分析考虑的讨论.

主要成果:

  • 确定了评估血液病治疗安全性和疗效的关键临床结果.
  • 强调了患者报告结果对于全面的治疗评估的重要性.
  • 提供了选择初级和二级终点的实际考虑.

结论:

  • 适当的选择和对结果和终点的统计分析对于血液学临床试验至关重要.
  • 临床结果对于确定治疗的安全性和有效性至关重要.
  • 患者报告的结果提高了对治疗有效性的综合评估.